Genome-Wide Analysis Identifies an Essential Human TBX3 Pacemaker Enhancer. Issue 12 (4th December 2020)

• Record Type: Journal Article
• Authors: van Eif, Vincent W.W.; Protze, Stephanie I.; Bosada, Fernanda M.; Yuan, Xuefei; Sinha, Tanvi; van Duijvenboden, Karel; Ernault, Auriane C.; Mohan, Rajiv A.; Wakker, Vincent; de Gier-de Vries, Corrie; Hooijkaas, Ingeborg B.; Wilson, Michael D.; Verkerk, Arie O.; Bakkers, Jeroen; Boukens, Bastiaan J.; Black, Brian L.; Scott, Ian C.; Christoffels, Vincent M.
• Is Part Of: Circulation research. Volume 127:Issue 12(2020)
• Publication Date: 2020-12-04
• Subjects: genetics -- heart rate -- human -- myocyte, cardiac -- stem cell; Cardiovascular system -- Periodicals; Blood -- Circulation -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; Sang -- Circulation -- Périodiques; Appareil cardiovasculaire -- Périodiques; 612.1
• DOI: 10.1161/CIRCRESAHA.120.317054
• Languages: English
• ISSNs: 0009-7330

Abstract

Abstract : Rationale: The development and function of the pacemaker cardiomyocytes of the sinoatrial node (SAN), the leading pacemaker of the heart, are tightly controlled by a conserved network of transcription factors, including TBX3 (T-box transcription factor 3), ISL1 (ISL LIM homeobox 1), and SHOX2 (short stature homeobox 2). Yet, the regulatory DNA elements (REs) controlling target gene expression in the SAN pacemaker cells have remained undefined. Objective: Identification of the regulatory landscape of human SAN-like pacemaker cells and functional assessment of SAN-specific REs potentially involved in pacemaker cell gene regulation. Methods and Results: We performed Assay for Transposase-Accessible Chromatin using sequencing on human pluripotent stem cell–derived SAN-like pacemaker cells and ventricle-like cells and identified thousands of putative REs specific for either human cell type. We validated pacemaker cell–specific elements in the SHOX2 and TBX3 loci. CRISPR-mediated homozygous deletion of the mouse ortholog of a noncoding region with candidate pacemaker-specific REs in the SHOX2 locus resulted in selective loss of Shox2 expression from the developing SAN and embryonic lethality. Putative pacemaker-specific REs were identified up to 1 Mbp upstream of TBX3 in a region close to MED13L harboring variants associated with heart rate recovery after exercise. The orthologous region was deleted in mice, which resulted in selective loss of expression of Tbx3 from the SAN and (cardiac) ganglia and in neonatal lethality. Expression of Tbx3 was maintained in other tissues including the atrioventricular conduction system, lungs, and liver. Heterozygous adult mice showed increased SAN recovery times after pacing. The human REs harboring the associated variants robustly drove expression in the SAN of transgenic mouse embryos. Conclusions: We provided a genome-wide collection of candidate human pacemaker-specific REs, including the loci of SHOX2, TBX3, and ISL1, and identified a link between human genetic variants influencing heart rate recovery after exercise and a variant RE with highly conserved function, driving SAN expression of TBX3 . Abstract : Supplemental Digital Content is available in the text.